Irbesartan is not an ACE inhibitor. It belongs to a different drug class called angiotensin II receptor blockers, or ARBs. The two classes lower blood pressure through the same hormonal system but work at different steps in the process, which leads to meaningful differences in side effects and how your body responds.
How ARBs and ACE Inhibitors Differ
Both drug classes target the renin-angiotensin system, a chain of chemical reactions your body uses to regulate blood pressure. Understanding where each drug intervenes explains why they’re not interchangeable.
Your kidneys produce an enzyme called renin, which kicks off a cascade: renin converts a protein in your blood into angiotensin I, an inactive molecule. A second enzyme, called angiotensin-converting enzyme (ACE), then converts angiotensin I into angiotensin II, a powerful hormone that tightens blood vessels and raises blood pressure.
ACE inhibitors (like lisinopril, enalapril, and ramipril) block that second enzyme, reducing the amount of angiotensin II your body produces. Irbesartan takes a different approach. It lets your body produce angiotensin II normally but blocks the receptor (called AT1) where angiotensin II binds to trigger vessel tightening. The hormone is still there; it just can’t do its job.
Why the Distinction Matters for Side Effects
The most practical difference between the two classes is cough. ACE inhibitors are well known for causing a persistent, dry cough that affects a significant number of users. This happens because blocking ACE also causes a buildup of other substances, including bradykinin, that irritate the airways. Since ARBs like irbesartan don’t interfere with ACE, they avoid this buildup. Dry cough with irbesartan is rare, and it’s one of the most common reasons doctors switch a patient from an ACE inhibitor to an ARB.
Both drug classes can raise potassium levels in the blood because both reduce the signal that tells your kidneys to excrete potassium. If you take irbesartan alongside potassium supplements, potassium-sparing diuretics, or salt substitutes that contain potassium, the risk of dangerously high potassium increases. Routine blood work to check potassium and kidney function is standard, typically annually for people taking it for high blood pressure and more frequently for those with heart failure or kidney disease.
Both ACE inhibitors and ARBs carry a serious warning about pregnancy. Drugs acting on the renin-angiotensin system during the second and third trimesters can cause severe harm to the developing baby, including kidney failure, skull abnormalities, and in some cases death. If you become pregnant while taking irbesartan, it should be stopped as soon as possible.
What Irbesartan Is Approved to Treat
The FDA has approved irbesartan for two specific uses. The first is high blood pressure, either on its own or combined with other blood pressure medications. Lowering blood pressure with irbesartan reduces the risk of strokes and heart attacks. The second approved use is diabetic kidney disease in people with type 2 diabetes who also have high blood pressure and significant protein in their urine. It is also sometimes prescribed off-label for heart failure.
Typical Dosing
For high blood pressure, the usual starting dose is 150 mg once a day, with a maximum of 300 mg once a day. For diabetic kidney disease, the target dose is 300 mg once a day. People who are dehydrated or salt-depleted, such as those on aggressive diuretic therapy or hemodialysis, typically start lower at 75 mg once a day. After you take a dose, blood levels peak within about 1.5 to 2 hours, and the drug stays active long enough (with a half-life of 11 to 15 hours) to work with once-daily dosing.
Switching Between the Two Classes
Because ARBs and ACE inhibitors target the same system, they’re generally not taken together. Combining them increases the risk of low blood pressure, high potassium, and kidney problems without adding enough benefit to justify those risks. If you’re on an ACE inhibitor and experiencing a persistent cough or other side effects, your doctor may switch you to irbesartan or another ARB as a direct substitute. The blood pressure lowering effect is comparable, and the transition is usually straightforward.